Immunic IMUX Stock
Immunic Price Chart
Immunic IMUX Financial and Trading Overview
| Immunic stock price | 1.2 USD |
| Previous Close | 1.67 USD |
| Open | 1.67 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 1100 |
| Day's Range | 1.59 - 1.68 USD |
| 52 Week Range | 1.11 - 11.76 USD |
| Volume | 433.51K USD |
| Avg. Volume | 1.12M USD |
| Market Cap | 73.27M USD |
| Beta (5Y Monthly) | 1.654964 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.11 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 19 USD |
IMUX Valuation Measures
| Enterprise Value | -21844668 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.9166667 |
| PEG Ratio (5 yr expected) | -0.05 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.80331063 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.237 |
Trading Information
Immunic Stock Price History
| Beta (5Y Monthly) | 1.654964 |
| 52-Week Change | -54.039% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.76 USD |
| 52 Week Low | 1.11 USD |
| 50-Day Moving Average | 1.66 USD |
| 200-Day Moving Average | 2.31 USD |
IMUX Share Statistics
| Avg. Volume (3 month) | 1.12M USD |
| Avg. Daily Volume (10-Days) | 413.42K USD |
| Shares Outstanding | 44.4M |
| Float | 36.5M |
| Short Ratio | 3.39 |
| % Held by Insiders | 18.41% |
| % Held by Institutions | 65.31% |
| Shares Short | 2.33M |
| Short % of Float | 5.37% |
| Short % of Shares Outstanding | 5.23% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -44.59% |
| Return on Equity (ttm) | -108.97% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -92246000 USD |
| Net Income Avi to Common (ttm) | -124871000 USD |
| Diluted EPS (ttm) | -3.51 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 97.11M USD |
| Total Cash Per Share (mrq) | 2.19 USD |
| Total Debt (mrq) | 2M USD |
| Total Debt/Equity (mrq) | 2.19 USD |
| Current Ratio (mrq) | 6.538 |
| Book Value Per Share (mrq) | 2.054 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -63976000 USD |
| Levered Free Cash Flow (ttm) | -34686752 USD |
Profile of Immunic
| Country | United States |
| State | NY |
| City | New York |
| Address | 1200 Avenue of the Americas |
| ZIP | 10036 |
| Phone | 332 255 9818 |
| Website | https://www.imux.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 73 |
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 3 clinical for treatment of multiple sclerosis, including relapsing multiple sclerosis and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
Q&A For Immunic Stock
What is a current IMUX stock price?
Immunic IMUX stock price today per share is 1.2 USD.
How to purchase Immunic stock?
You can buy IMUX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Immunic?
The stock symbol or ticker of Immunic is IMUX.
Which industry does the Immunic company belong to?
The Immunic industry is Biotechnology.
How many shares does Immunic have in circulation?
The max supply of Immunic shares is 107.91M.
What is Immunic Price to Earnings Ratio (PE Ratio)?
Immunic PE Ratio is now.
What was Immunic earnings per share over the trailing 12 months (TTM)?
Immunic EPS is -2.11 USD over the trailing 12 months.
Which sector does the Immunic company belong to?
The Immunic sector is Healthcare.
Immunic IMUX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}